Background: Recent evidence suggests that aldosterone decreases insulin sensitivity independent of its effects on blood pressure. This article discusses the evidence linking aldosterone to insulin resistance. Objective: The role of aldosterone in causing alterations in insulin sensitivity might be relevant in patients with inappropriately elevated circulating levels of the hormone. Aldosterone and insulin resistance might together contribute to blood pressure raise and, eventually, increased cardiovascular risk. Discussion: Evidence obtained in studies of patients with primary aldosteronism suggests that inappropriately elevated plasma aldosterone levels contribute to insulin resistance. However, the relative contribution of circulating aldosterone levels or hypertensive state itself to insulin resistance is not entirely clear. Summary: Aldosterone antagonists might be beneficial in conditions associated with insulin resistance, but more research is needed to test this hypothesis.
Role of Aldosterone in Insulin Resistance: Fact of Fantasy
Leonardo A. Sechi;Gianluca Colussi;Cristiana Catena
2015-01-01
Abstract
Background: Recent evidence suggests that aldosterone decreases insulin sensitivity independent of its effects on blood pressure. This article discusses the evidence linking aldosterone to insulin resistance. Objective: The role of aldosterone in causing alterations in insulin sensitivity might be relevant in patients with inappropriately elevated circulating levels of the hormone. Aldosterone and insulin resistance might together contribute to blood pressure raise and, eventually, increased cardiovascular risk. Discussion: Evidence obtained in studies of patients with primary aldosteronism suggests that inappropriately elevated plasma aldosterone levels contribute to insulin resistance. However, the relative contribution of circulating aldosterone levels or hypertensive state itself to insulin resistance is not entirely clear. Summary: Aldosterone antagonists might be beneficial in conditions associated with insulin resistance, but more research is needed to test this hypothesis.File | Dimensione | Formato | |
---|---|---|---|
Endo and Metab Sdr 2015.pdf
non disponibili
Descrizione: Endo and Metab Sdr 2015
Tipologia:
Documento in Post-print
Licenza:
Non pubblico
Dimensione
300.44 kB
Formato
Adobe PDF
|
300.44 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.